Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.076 AUD | +1.33% | +1.33% | +10.14% |
04-17 | Neurotech's Phase II/III NTIASD2 Clinical Trial for Children with Autism Meets Primary Endpoint | MT |
04-17 | Neurotech International Completes AU$10 Million Capital Raise | MT |